Windham Venture Partners

@windhamvp

February 22, 2021

NovellusDx Establishes Fore Biotherapeutics U.S. as its Operating Company in the United States & Appoints Dieter Weinand as Chairman of the Board & Usama Malik as Chief Executive Officer and Director of the Board

 Company launch and rebrand in the US reflects expert leadership in precision oncology and a new business model optimized for speed to market by hyper-targeting patient populations with unaddressed tumor … Continued

February 10, 2021

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Proceeds to Support Expansion of Commercial Infrastructure Driving Decentralization of Comprehensive Genomic Profiling for Cancer PGDx’s elio™ Platform and Bioinformatics Solution Enable Hospitals and Labs to Deliver World-Class, Actionable Genomic … Continued

February 03, 2021

Valera Health announces a $3.8M round led by AXA Venture Partners

NEWS PROVIDED BY Valera Health  BROOKLYN, N.Y., Feb. 3, 2021 /PRNewswire/ — Valera Health, a tele-behavioral health service that provides personalized team-based clinical care, announced the closing of a $3.8M round led by AXA … Continued

Archives

© 2024 Windham Venture Partners 500 Fifth Avenue, Suite 3600, NY, NY 10110